Related Experiment Video
Updated: May 28, 2026
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Cell-cycle-dependent variations in the FTIR spectroscopy of HeLa cells treated with trichostatin A
Feng-Qiu Zhang1, Jian Qi, Zhan-Guo Yang
1School of Physical Engineering, Zhengzhou University, Zhengzhou 450052, China. zhangfengqiu@zzu.edu.cn
Abstract:
It is quite complex to evaluate the mechanism of action for antitumor drugs on cancer cells. Studies have pointed out that there is an unique advantage of Fourier transform infrared spectrum to obtain a fingerprint of all molecules present in the cells when cancer cells were exposed to anti-cancer drugs. Trichostatin A (TSA) is a most potent reversible inhibitor of mammalian histone deacetylases. It can inhibit cancer cell growth in vitro and in vivo. In the present study, HeLa cells were exposed to 0, 50, 100, 200, 300 and 400 nmol x L(-1) TSA, and FTIR spectra were applied to evaluate the effect of TSA on cancer cells. Results show that there is some significant relationship between the changes in FTIR absorption and cell cycle arresting. On the other hand, this investigation shows that the concentration of TSA had to be more than 200 nmol x L(-1) in order to ensure A1080 cm(-1)/A1540 cm(-1) > or = 1 for inhibiting cell proliferation.
Insights
Fourier transform infrared (FTIR) spectroscopy reveals how Trichostatin A (TSA) affects cancer cells. Higher TSA concentrations are needed to inhibit cell proliferation, correlating with cell cycle changes.
Area of Science:
- Biochemistry
- Cell Biology
- Spectroscopy
Background:
- Evaluating antitumor drug mechanisms in cancer cells is complex.
- Fourier transform infrared (FTIR) spectroscopy offers a unique method to analyze molecular changes in cells exposed to anti-cancer drugs.
- Trichostatin A (TSA) is a potent inhibitor of histone deacetylases, known to suppress cancer cell growth.
Purpose of the Study:
- To investigate the effects of Trichostatin A (TSA) on HeLa cancer cells using FTIR spectroscopy.
- To establish a correlation between FTIR spectral changes and cell cycle arrest induced by TSA.
- To determine the minimum TSA concentration required for significant cell proliferation inhibition.
Main Methods:
- HeLa cells were treated with varying concentrations of TSA (0-400 nmol x L(-1)).
- FTIR spectra were acquired to analyze molecular alterations within the cells.
- Spectral data, specifically the ratio A1080 cm(-1)/A1540 cm(-1), was correlated with cell proliferation inhibition.
Main Results:
- Significant relationships were observed between changes in FTIR absorption patterns and cell cycle arresting.
- TSA exposure led to distinct spectral modifications in HeLa cells.
- A TSA concentration exceeding 200 nmol x L(-1) was required to achieve an A1080 cm(-1)/A1540 cm(-1) ratio of 1 or greater, indicating inhibition of cell proliferation.
Conclusions:
- FTIR spectroscopy is a valuable tool for assessing the impact of antitumor agents like TSA on cancer cells.
- TSA concentrations above 200 nmol x L(-1) are necessary to effectively inhibit HeLa cell proliferation.
- The observed spectral changes are linked to TSA-induced cell cycle alterations, providing insights into its mechanism of action.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
